Nasdaq
IPHA
Innate Pharma S.A.
- Health Care
- France
- Listed 2019
- 1 day
- +0.8%
- 1 month
- −6.0%
- 1 year
- −16.8%
$1.79 · Mkt cap $167M
At the 6 Aug 2026 close
A foreign company trading in the US through depositary receipts.
Nasdaq
Innate Pharma S.A.
$1.79 · Mkt cap $167M
At the 6 Aug 2026 close
A foreign company trading in the US through depositary receipts.
Innate Pharma S.A. trades under the ticker IPHA on Nasdaq, in the Health Care sector (Biotechnology: Biological Products (No Diagnostic Substances)). It has been listed since 2019. Its market capitalisation is $167M. The last closing price was $1.79, on 6 Aug 2026. No price-to-earnings ratio is shown, because it did not report positive earnings in its last annual filing. Over the past year the share price is −16.8%, and −6.0% over the past month. Returns are price returns and exclude dividends.
This page exists because IPHA is one of the shares What A Share can show you. It is not a recommendation, and its appearance here says nothing about whether the company is worth owning.